P. Corris

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

L. Saiman, I. Sermet-Gaudelus, J. Herrmann, 2015, Thorax.

Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema.

P. Corris, I. Purcell, P. Corris, 1995, Thorax.

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

R. Gibson, L. Saiman, P. Corris, 2015, Thorax.

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

Henning Gall, Andrea Olschewski, Horst Olschewski, 2018, Nature Communications.

Algorithm of Pulmonary Arterial Hypertension

W. Seeger, Z. Jing, P. Corris, 2022 .

Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.

P. Corris, D. Kiely, R. Condliffe, 2009, American journal of respiratory and critical care medicine.

Identification of rare sequence variation underlying heritable pulmonary arterial hypertension

N. Soranzo, Q. Waisfisz, M. Haimel, 2018, Nature Communications.

Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension

Sri V. V. Deevi, Eleanor F. Dewhurst, Lorena E. Lorenzo, 2017, Circulation.

De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures

Henning Gall, Fengyuan Hu, Kevin Rue-Albrecht, 2018, American journal of human genetics.